CONTACT INFORMATION http://www.loyola.org
Ellen R. Gaynor
M.D.
  • Professor
  • Hematology/Oncology
Specialties
Prostate Cancer, Breast Cancer, Gastrointestinal Cancers, General Oncology
Board Certifications
  • Hematology - Subspecialty Cert: AM Board of Internal Medicine
  • Internal Medicine - General Cert: AM Board of Internal Medicine
  • Medical Oncology - Subspecialty Cert: AM Board of Internal Medicine
Publications

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.Lo,S. S.; Mumby,P. B.; Norton,J.; Rychlik,K.; Smerage,J.; Kash,J.; Chew,H. K.; Gaynor,E. R.; Hayes,D. F.; Epstein,A.; Albain,K. S.Journal of Clinical Oncology 2010 ;28(10):1671-1676

Octreotide for refractory diarrhea associated with capecitabineTanvetyanon,T.; Gaynor,E. R.Journal of Pharmacy Technology 2004 ;20(4):226-228

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group studyWhitehead,R. P.; Benedetti,J. K.; Abbruzzese,J. L.; Ardalan,B.; Williamson,S.; Gaynor,E. R.; Balcerzak,S. P.; Macdonald,J. S.Investigational new drugs 2004 ;22(4):467-473

Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133Ganz,P. A.; Moinpour,C. M.; Pauler,D. K.; Kornblith,A. B.; Gaynor,E. R.; Balcerzak,S. P.; Gatti,G. S.; Erba,H. P.; McCoy,S.; Press,O. W.; Fisher,R. I.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 ;21(18):3512-3519

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911Press,O. W.; Unger,J. M.; Braziel,R. M.; Maloney,D. G.; Miller,T. P.; LeBlanc,M.; Gaynor,E. R.; Rivkin,S. E.; Fisher,R. I.Blood 2003 ;102(5):1606-1612

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349)Blayney,D. W.; LeBlanc,M. L.; Grogan,T.; Gaynor,E. R.; Chapman,R. A.; Spiridonidis,C. H.; Taylor,S. A.; Bearman,S. I.; Miller,T. P.; Fisher,R. I.; Southwest Oncology GroupJournal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 ;21(13):2466-2473

Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's diseasePress,O. W.; LeBlanc,M.; Lichter,A. S.; Grogan,T. M.; Unger,J. M.; Wasserman,T. H.; Gaynor,E. R.; Peterson,B. A.; Miller,T. P.; Fisher,R. I.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001 ;19(22):4238-4244

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group StudyGaynor,E. R.; Unger,J. M.; Miller,T. P.; Grogan,T. M.; White,L. A.,Jr; Mills,G. M.; Balcerzak,S. P.; Varterasian,M.; LeBlanc,M.; Fisher,R. I.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001 ;19(3):750-755

Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809Fisher,R. I.; Dana,B. W.; LeBlanc,M.; Kjeldsberg,C.; Forman,J. D.; Unger,J. M.; Balcerzak,S. P.; Gaynor,E. R.; Roy,V.; Miller,T.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 ;18(10):2010-2016

Education
Medical School
  • University of Wisconsin Medical School
Residency
  • Loyola University Medical Center, Internal Medicine: General
  • Loyola University Medical Center, Internal Medicine: General
Fellowship
  • University of Chicago Hospitals and Clinics, Internal Medicine: Hematology & Medical Oncology
  • Loyola University Medical Center, Internal Medicine: Medical Oncology